InvestorLens

NTLA — INTELLIA THERAPEUTICS INC

Public company

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying NTLA?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
67
Institutional Conviction
Mixed · 2 buying vs 1 selling last quarter
52
Macro Tailwind
Macro conditions are mixed for this sector
52
Why? — Evidence & Confidence ▾

Of 3 tracked investors who changed their NTLA position last quarter, 2 bought and 1 sold (67% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).

Supporting evidence
  • +2 tracked investors added or increased positions last quarter (Paul Tudor Jones, Cathie Wood)
  • +6 tracked investors reported holding NTLA at their latest filing
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.

About INTELLIA THERAPEUTICS INC (NTLA)

INTELLIA THERAPEUTICS INC (NTLA) appears in the most recent 13F filings of 6 tracked institutional investors. The largest disclosed position is held by Cathie Wood (ARK Investment Management), valued at $206M. Across recent filings, tracked investors recorded 4 new positions, 3 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in NTLA

88
/100
Strong Institutional Accumulation
Added / Increased7
Reduced0
Exited1
BearishBullish
Crowded Trade Score™

How many top investors track NTLA

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

NTLA Ownership Composition

How INTELLIA THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Growth Funds
89% of tracked value
Institutions
6
tracked investors
Total Reported
$208.2M
combined 13F value
Sectors3
  • Growth Funds89.3%
  • Other8.8%
  • Hedge Funds1.8%
Growth Funds(1)
89.3%
Other(4)
8.8%
Hedge Funds(1)
1.8%

Tracked investors reporting NTLA

  • Cathie WoodMar 31, 2026
    ARK Investment Management
    Shares
    14.5M
    Value
    $186M
    % Portfolio
    1.45%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    1.1M
    Value
    $14.3M
    % Portfolio
    0.00%
  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    297K
    Value
    $3.8M
    % Portfolio
    0.00%
  • Ray DalioDec 31, 2025
    Bridgewater Associates
    Shares
    223.2K
    Value
    $2M
    % Portfolio
    0.03%
  • Paul Tudor JonesMar 31, 2026
    Tudor Investment Corp
    Shares
    89.2K
    Value
    $1.1M
    % Portfolio
    0.00%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    70.6K
    Value
    $904.6K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold NTLA?
6 tracked institutional investors disclosed a position in NTLA (INTELLIA THERAPEUTICS INC) in their most recent 13F filing.
Who is the largest institutional holder of NTLA?
Cathie Wood, ARK Investment Management, holds the largest disclosed position in NTLA, valued at $206M.
Did institutional ownership of NTLA increase or decrease?
Across recent 13F filings, tracked investors recorded 4 new positions, 3 increased, 0 reduced, and 1 fully exited NTLA.
Where does this NTLA ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.